BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
753 results:

  • 1. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
    Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
    J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CD146 Promotes emt-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway.
    Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma.
    Chen Y; Ji Y; Shen L; Li Y; Ren Y; Shi H; Li Y; Wu Y
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):214. PubMed ID: 38662050
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression.
    Wu J; Wen T; Marzio A; Song D; Chen S; Yang C; Zhao F; Zhang B; Zhao G; Ferri A; Cheng H; Ma J; Ren H; Chen QY; Yang Y; Qin S
    Cell Death Dis; 2024 Apr; 15(4):282. PubMed ID: 38643215
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Degradation of FAK-targeting by proteolytic targeting chimera technology to inhibit the metastasis of hepatocellular carcinoma.
    Zhang X; Li S; Song M; Chen Y; Chang L; Liu Z; Dai H; Wang Y; Yang G; Jiang Y; Lu Y
    Oncol Res; 2024; 32(4):679-690. PubMed ID: 38560575
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Silencing of circ_0088036 inhibits growth and invasion of lung adenocarcinoma through miR-203/SP1 axis.
    Liu X; Feng Y; Wang L; Shi L; Ji K; Hu N; Du Y; Liu M; Wang M
    J Biochem Mol Toxicol; 2024 Apr; 38(4):e23684. PubMed ID: 38533528
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Construction of a prognostic model with CAFs for predicting the prognosis and immunotherapeutic response of lung squamous cell carcinoma.
    Zhang X; Xiao Q; Zhang C; Zhou Q; Xu T
    J Cell Mol Med; 2024 Apr; 28(8):e18262. PubMed ID: 38520221
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inhibition of PD-L1 expression in non-small cell lung cancer may reduce vasculogenic mimicry formation by inhibiting the epithelial mesenchymal transformation process.
    Shi Y; Li W; Jia Q; Wu J; Wu S; Wu S
    Exp Cell Res; 2024 Apr; 437(1):113996. PubMed ID: 38508327
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Canonical DDR activation by emt inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression.
    Mir KB; Chakraborty S; Amin T; Kumar A; Rouf War A; Nalli Y; Kumar R; Dinesh Kumar L; Ali A; Goswami A
    Biochem Pharmacol; 2024 May; 223():116126. PubMed ID: 38490521
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells.
    Parodi M; Centonze G; Murianni F; Orecchia P; Andriani F; Roato I; Gardelli C; Balsamo M; Moro M; Taiè G; Pastorino U; Petretto A; Lavarello C; Milione M; Sozzi G; Roz L; Vitale M; Bertolini G
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38458638
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast cancer by Activating Notch Signaling.
    Li B; Huang L; Ruan J
    Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Exploring the molecular and immune-landscape of lung cancer associated with cystic airspaces.
    Zheng X; Qiu L; Huang Y; Cheng R; Huang S; Xu K; Cai W; Deng Y; Wang W; Zhong X; Cui F; Hao Z; Liu J
    Mol Immunol; 2024 Apr; 168():75-88. PubMed ID: 38430689
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the emt and metastasis of lung adenocarcinoma.
    Hu Z; Sui Q; Jin X; Shan G; Huang Y; Yi Y; Zeng D; Zhao M; Zhan C; Wang Q; Lin Z; Lu T; Chen Z
    J Exp Clin Cancer Res; 2024 Feb; 43(1):63. PubMed ID: 38424624
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. JAM2 is a prognostic biomarker and inhibits proliferation, metastasis and epithelial-mesenchymal transition in lung adenocarcinoma.
    Dong Y; Zhang J; Xie S; Di S; Fan B; Gong T
    J Gene Med; 2024 Feb; 26(2):e3679. PubMed ID: 38404047
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The role and regulation of SIRT1 in pulmonary fibrosis.
    Ma X; Jiang M; Ji W; Yu M; Tang C; Tian K; Gao Z; Su L; Tang J; Zhao X
    Mol Biol Rep; 2024 Feb; 51(1):338. PubMed ID: 38393490
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma.
    Joseph AM; Al Aiyan A; Al-Ramadi B; Singh SK; Kishore U
    Front Immunol; 2024; 15():1323198. PubMed ID: 38384463
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway.
    Takeda T; Tsubaki M; Genno S; Tomita K; Nishida S
    Exp Cell Res; 2024 Mar; 436(2):113978. PubMed ID: 38382805
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial-mesenchymal transition in lung adenocarcinoma.
    Xia X; Ge Y; Ge F; Gu P; Liu Y; Li P; Xu P
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):88. PubMed ID: 38341398
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Acidity-induced ITGB6 promote migration and invasion of lung cancer cells by epithelial-mesenchymal transition and focal adhesion.
    Liu L; He Z; Jiang Z; Liu Z; Zhuang X
    Exp Cell Res; 2024 Mar; 436(1):113962. PubMed ID: 38316250
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. lncRNA CYTOR promotes lung adenocarcinoma gemcitabine resistance and epithelial-mesenchymal transition by sponging miR-125a-5p and upregulating ANLN and RRM2.
    Cao Q; Wang H; Zhu J; Qi C; Huang H; Chu X
    Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):210-222. PubMed ID: 38273783
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 38.